Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Nano-X Imaging Ltd.NASDAQ: NNOX
Free Cash Flow · Q4 FY2025 · quarter ended Dec 2025
Free cash flow grows, but more slowly than its trailing trend
Q4 FY2025 free cash flow of $12.49M (cash outflow) rose 8.0% year over year, behind the +21.0% change in trailing-twelve-month free cash flow. Sequentially, it fell 10.2% from the prior quarter. Over 3 fiscal years it compounded at -3.8% a year.
Context
- Free cash flow amounted to 345.6% of revenue in FY2025, down 3.3 pp from a year earlier.
- Free cash flow grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +8.0% toward the trailing-twelve-month pace of +21.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (45M) USD
- Year-over-year change
- -14.3%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (45M) | -14.3% |
| FY2024 | 2024-12-31 | (39.37M) | +18.1% |
| FY2023 | 2023-12-31 | (48.08M) | +4.9% |
| FY2022 | 2022-12-31 | (50.56M) | +17.4% |
| FY2021 | 2021-12-31 | (61.23M) | — |
Free Cash Flow vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's LTM Dec 2025 free cash flow of $47.63M is the 3rd largest of the 11 companies compared; the peer median is $24.9M.
- Its year-over-year change of +21.0% is the 6th highest of 11, against a peer median of +24.0%.
- Free cash flow amounts to 365.8% of revenue for NNOX, versus a peer median of 51.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $107.32M | +3.5% | +96.9% | 17365.9% | |
| LTM Mar 2026 | $82.9M | +151.2% | +10.0% | 57.2% | |
| LTM Dec 2025 | $47.63M | +21.0% | -3.8% | 365.8% | |
| LTM Mar 2026 | $38.97M | +44.5% | +14.8% | 206.5% | |
| LTM Mar 2026 | $34.25M | -64.6% | -32.6% | 29.1% | |
| LTM Mar 2026 | $29.51M | -10.5% | +2.8% | 91.4% | |
| LTM Mar 2026 | $20.3M | -42.8% | -17.0% | 45.2% | |
| LTM Mar 2026 | $17.81M | +53.8% | +62.3% | 185.7% | |
| LTM Mar 2026 | $10.24M | -51.5% | -28.4% | 2.9% | |
| LTM Mar 2026 | $9.17M | +194.8% | -83.5% | 3.0% | |
| LTM Mar 2026 | $5.86M | +937.6% | — | 13.2% | |
| Peer median (excluding NNOX) | $24.9M | +24.0% | +2.8% | 51.2% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| Deferred Income Tax | (116K) | (3.73M) | (377K) | (377K) | (1.98M) |
| Stock-Based Compensation | 18.81M | 18.62M | 6.84M | 7.26M | 4.19M |
| Change in Working Capital | 2.75M | (16.95M) | (7.48M) | (1.13M) | 2.77M |
| Accounts Receivables | (40K) | 74K | (507K) | (321K) | 107K |
| Inventory | 864K | 0 | 0 | (277K) | (325K) |
| Accounts Payables | 1.72M | 469K | (153K) | (1.32M) | 288K |
| Other Working Capital | 202K | (17.49M) | (6.82M) | 787K | 2.7M |
| Other Non-Cash Items | (2K) | 52.4M | 5.21M | (572K) | 17.54M |
| Operating Cash Flow | (38.07M) | (43.39M) | (44.78M) | (36.6M) | (40.79M) |
| Capital Expenditures | (23.16M) | (7.17M) | (3.3M) | (2.77M) | (4.21M) |
| Acquisitions (Net) | (2.86M) | 1.01M | 0 | 0 | 0 |
| Purchases of Investments | (90.3M) | (9.46M) | (373K) | (58.52M) | (15K) |
| Sales of Investments | 90.3M | 31.24M | 39.11M | 41.19M | 33.8M |
| Other Investing Activities | (90.3M) | (1.01M) | (373K) | 46K | (200K) |
| Investing Cash Flow | (116.32M) | 14.61M | 35.43M | (20.05M) | 29.37M |
| Debt Repayment | 3.8M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 3.58M | 949K | 27.14M | 37.83M | 21.37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.58M | 804K | 113K | 1.67M | 0 |
| Financing Cash Flow | 7.38M | 804K | 27.25M | 39.5M | 21.37M |
| Effect of Forex Changes | (10K) | (268K) | (60K) | 72K | (101K) |
| Net Change in Cash | (147.01M) | (28.24M) | 17.85M | (17.07M) | 9.85M |
| Free Cash Flow | (61.23M) | (50.56M) | (48.08M) | (39.37M) | (45M) |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.